Yastremska, 20, offered the pattern in November and a WADA lab in Montreal discovered the presence of mesterolone metabolite, an anabolic agent on its Prohibited Checklist.
“Yastremska was charged with an Anti-Doping Rule Violation below Article 2.1 of the Programme (presence of a Prohibited Substance in a Participant’s Pattern) and was provisionally suspended with impact from Jan. 7,” the ITF mentioned.
“Yastremska had (and retains) the appropriate to use to the Chair of the Impartial Tribunal convened to listen to her case why the Provisional Suspension shouldn’t be imposed, however has chosen to not train that proper up to now.”
— Dayana Yastremska (@D_Yastremska) 1610032263000
Yastremska, ranked 29 on the planet, denied having used efficiency enhancing medicine and believes the constructive check was the results of a “contamination occasion”.
“I am astonished and below shock, notably provided that two weeks previous to this check… I examined detrimental on the WTA occasion in Linz. After this final match of the yr, I finished training to relaxation previous to the beginning of the brand new season,” she mentioned in a press release.
“Solely a really low focus of mesterolone metabolite was detected in my urine. On condition that low focus and given my detrimental check two weeks earlier, I’ve obtained scientific recommendation that the result’s in line with some type of contamination occasion.”
The ITF didn’t say when Yastremska’s listening to would happen, placing her participation within the Feb. 8-21 Australian Open unsure.